QuidelOrtho (QDEL) Capital Expenditures Growth (3y) (2024 - 2026)
QuidelOrtho (QDEL) Capital Expenditures Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 2.15% |
| 10 | QuidelOrtho | 1.18 Bn | 1.04 Bn | - | -19.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -19.84% |
| Dec 28, 2025 | 33.50% |
| Mar 30, 2025 | 35.68% |
| Sep 29, 2024 | -24.23% |